🕵️ Adicet BIO, Inc. ($ACET)
SEC insider & ownership activity, last 12 months · CIK 1720580 · every row links its SEC filing
Over the last 12 months insiders sold $675K against $6.6M of open-market buying. Orbimed Advisors LLC bought $5.0M in discretionary trades (Oct–Apr). Orbimed Advisors LLC trimmed 9.6% → 8.8%. One red-flag 8-K in the window: Delisting notice (3.01), Oct 7, 2025.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
2 buyers, $6.6M (5 lots) · 1 seller, $675K (4 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Orbimed Advisors LLC | 2 | $5.0M | 4 | $675K | Apr 8, 2026 |
| RA Capital Management, L.P. | 3 | $1.6M | 0 | – | Feb 20, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| RA Capital Management, L.P. | 12.3% | 13G | Apr 13, 2026 | filing ↗ | |
| Peter Kolchinsky | 12.3% | 13G | Apr 13, 2026 | filing ↗ | |
| Rajeev Shah | 12.3% | 13G | Apr 13, 2026 | filing ↗ | |
| RA Capital Healthcare Fund, L.P. | 12.3% | 13G | Apr 13, 2026 | filing ↗ | |
| Orbimed Advisors LLC | 8.8% | 13D | Apr 8, 2026 | filing ↗ | |
| Franklin Resources, Inc. | 6.5% | 13G | Jan 29, 2026 | filing ↗ | |
| Franklin Advisers, Inc. | 6.5% | 13G | Jan 29, 2026 | filing ↗ | |
| Orbimed Capital GP V LLC | 5.9% | 13D | Apr 8, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Orbimed Genesis Master Fund, L.P. | $514K | Apr 9, 2026 | filing ↗ |
| Orbimed Israel Partners II, L.P. | $265K | Apr 8, 2026 | filing ↗ |
| Orbimed Israel Partners Limited Partnership | $413K | Apr 7, 2026 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Shareholder vote (5.07) | Jun 17, 2026 | filing ↗ |
| Earnings (2.02) | May 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 13, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Apr 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 27, 2026 | filing ↗ |
| Earnings (2.02) | Mar 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 12, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 7, 2026 | filing ↗ |
| Other events (8.01) | Jan 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 7, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Dec 26, 2025 | filing ↗ |
| Other events (8.01) | Dec 26, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 26, 2025 | filing ↗ |
| Shareholder vote (5.07) | Dec 19, 2025 | filing ↗ |
| Earnings (2.02) | Nov 5, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 5, 2025 | filing ↗ |
| Delisting notice (3.01) | Oct 7, 2025 | filing ↗ |
| Material agreement (1.01) | Oct 7, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 7, 2025 | filing ↗ |
| Other events (8.01) | Oct 7, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 7, 2025 | filing ↗ |
| Earnings (2.02) | Aug 7, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 7, 2025 | filing ↗ |